The following survey aims to map the educational efforts about biological medicines, including biosimilars, incorporated in the current curricula for the future pharmacists. This survey aims to address the Deans office, program directors or Faculty coordinators of your institution, not the students.

This survey is part of the academic research program of the MABEL Fund (“Market Analysis of Biologics and Biosimilars following loss of exclusivity”). The MABEL Fund is a collaboration between the University of Leuven (KU Leuven, Belgium) and the Erasmus University Medical Centre (The Netherlands) and investigates the off-patent biological medicines market.

The survey will take approximately 15 minutes to complete. Your answers will be anonymized and will be treated confidentially.

If you have any questions, please feel free to contact us via the following e-mail addresses:
liese.barbier@kuleuven.be or a.vulto@gmail.com 

Thank you in advance for your participation!

With kind regards,

PhD researcher Liese Barbier (KU Leuven, Leuven, Belgium)
Prof. Arnold G. Vulto (Erasmus University Medical Centre, Rotterdam, the Netherlands)

For more information about our research, please visit: https://pharm.kuleuven.be/clinpharmacotherapy/mabel